Showing results (311-320 of 391) with videos related to

Sort By:
Pageof 40
Journal of Medicinal Chemistry|April 13, 2024
Discovery of Novel Aryl Triazolone Dihydropyridines (ATDPs) Targeting Highly Conserved Residue W229 as Promising HIV-1 NNRTIsYanying Sun, Zhenzhen Zhou, Na Wang, et al.
European Journal of Medicinal Chemistry|September 22, 2019
Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial librariesLanlan Jing, Gaochan Wu, Xia Hao, et al.
European Journal of Medicinal Chemistry|February 24, 2015
Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazinesBoshi Huang, Xin Liang, Cuicui Li, et al.
European Journal of Medicinal Chemistry|October 11, 2022
Design, synthesis and activity evaluation of novel lesinurad analogues containing thienopyrimidinone or pyridine substructure as human urate transporter 1 inhibitorsJian Zhang, Yue Dong, Shenghua Gao, et al.
European Journal of Medicinal Chemistry|February 18, 2020
Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activitiesLin Sun, Tianguang Huang, Alexej Dick, et al.
Science Advances|May 30, 2025
Development of enhanced HIV-1 non-nucleoside reverse transcriptase inhibitors with improved resistance and pharmacokinetic profilesZhao Wang, Shawn Rumrill, Dongwei Kang, et al.
Journal of Medicinal Chemistry|December 7, 2024
Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance ProfilesJiwei Zhang, Ruifang Jia, Huinan Jia, et al.
Translational Oncology|December 9, 2021
CD169-positive macrophages enhance abscopal effect of radiofrequency ablation therapy in liver cancerXiaojia Song, Na Li, Yuan Liu, et al.
European Journal of Medicinal Chemistry|January 1, 2021
Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavityRuifang Jia, Jian Zhang, Chiara Bertagnin, et al.
European Journal of Medicinal Chemistry|June 26, 2018
5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integraseLin Sun, Ping Gao, Guanyu Dong, et al.
Pageof 40